TickerFacts.

Keros Therapeutics, Inc. (KROS): Share Repurchases

Annual figures by period end, from SEC filings.

$375.00M
Year ended 2025-12-31
2024-12-31: $02025-12-31: $375.00M$375.00M
2024-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$375.00Mn/a2026-03-04, From 2025-01-01
2024-12-31$0n/a2026-03-04, From 2024-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Keros Therapeutics, Inc. (KROS)2025-12-31$375.00Mn/a
Anaptysbio, Inc (ANAB)2025-12-31$68.63Mn/m
Arvinas, Inc. (ARVN)2025-12-31$91.90Mn/a
Ligand Pharmaceuticals Inc (LGND)2025-12-31$15.00Mn/a
Lifevantage Corp (LFVN)2026-06-30$2.04M-35.1%
Cryoport, Inc. (CYRX)2025-12-31$10.01Mn/a
Innoviva, Inc. (INVA)2025-12-31$4.53M-69.3%
Nature's Sunshine Products Inc (NATR)2025-12-31$16.31M+84.1%
BridgeBio Pharma, Inc. (BBIO)2025-12-31$48.28Mn/a

Compare KROS, ANAB, ARVN, LGND side by side · Screen every company in Pharmaceutical Preparations ↗